Some remarks about the LeishVet directions for the treatment of canine leishmaniasis.
Lamothe
J
J
D000493:Allopurinol / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy* / Q000469:parasitology / Q000635:transmission; D004285:Dogs; D004351:Drug Resistance; D017408:Guidelines as Topic; D007896:Leishmaniasis / Q000188:drug therapy / Q000635:transmission / Q000662:veterinary*; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D000493:Allopurinol; D008536:Meglumine; D000077485:Meglumine Antimoniate